Analysts’ Upgrades for December 2nd (AKAM, ARCC, DAN, EMA, EMBC, FMS, FSLY, GAP, GMED, IAG)

Analysts’ upgrades for Monday, December 2nd:

Akamai Technologies (NASDAQ:AKAM) was upgraded by analysts at Oppenheimer Holdings Inc. from a market perform rating to an outperform rating. Oppenheimer Holdings Inc. currently has $120.00 price target on the stock.

Ares Capital (NASDAQ:ARCC) was upgraded by analysts at Wells Fargo & Company from an equal weight rating to an overweight rating. They currently have $23.00 price target on the stock.

Dana (NYSE:DAN) was upgraded by analysts at Barclays PLC from an equal weight rating to an overweight rating. The firm currently has $18.00 price target on the stock, up from their previous price target of $12.00.

Emera (TSE:EMA) was upgraded by analysts at CIBC from a neutral rating to an outperform rating. CIBC currently has C$58.00 target price on the stock, up from their previous target price of C$54.00.

Embecta (NASDAQ:EMBC) was upgraded by analysts at Morgan Stanley from an underweight rating to an equal weight rating. They currently have $20.00 price target on the stock, up from their previous price target of $13.00.

Fresenius Medical Care (NYSE:FMS) was upgraded by analysts at Bank of America Co. from an underperform rating to a neutral rating.

Fastly (NYSE:FSLY) was upgraded by analysts at Oppenheimer Holdings Inc. from a market perform rating to an outperform rating. Oppenheimer Holdings Inc. currently has $12.00 target price on the stock.

GAP (NYSE:GAP) was upgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an overweight rating. JPMorgan Chase & Co. currently has $30.00 target price on the stock, up from their previous target price of $28.00.

Globus Medical (NYSE:GMED) was upgraded by analysts at Morgan Stanley from an equal weight rating to an overweight rating. Morgan Stanley currently has $100.00 price target on the stock, up from their previous price target of $83.00.

IAMGOLD (NYSE:IAG) (TSE:IMG) was upgraded by analysts at CIBC from a neutral rating to a sector outperform rating.

Intuitive Surgical (NASDAQ:ISRG) was upgraded by analysts at Morgan Stanley from an equal weight rating to an overweight rating. The firm currently has $650.00 target price on the stock, up from their previous target price of $522.00.

Kewaunee Scientific (NASDAQ:KEQU) was upgraded by analysts at StockNews.com from a hold rating to a buy rating.

Kymera Therapeutics (NASDAQ:KYMR) was upgraded by analysts at Wells Fargo & Company from an equal weight rating to an overweight rating. The firm currently has $57.00 target price on the stock, up from their previous target price of $38.00.

LVMH Moët Hennessy – Louis Vuitton, Société Européenne (OTCMKTS:LVMUY) was upgraded by analysts at HSBC Holdings plc from a hold rating to a buy rating.

NextEra Energy Partners (NYSE:NEP) was upgraded by analysts at Morgan Stanley from an equal weight rating to an overweight rating. The firm currently has $22.00 target price on the stock.

Cloudflare (NYSE:NET) was upgraded by analysts at Morgan Stanley from an equal weight rating to an overweight rating. Morgan Stanley currently has $130.00 price target on the stock, up from their previous price target of $92.00.

NovoCure (NASDAQ:NVCR) was upgraded by analysts at Evercore ISI from an in-line rating to an outperform rating. They currently have $30.00 price target on the stock, up from their previous price target of $18.00.

Okta (NASDAQ:OKTA) was upgraded by analysts at Morgan Stanley from an equal weight rating to an overweight rating. Morgan Stanley currently has $97.00 target price on the stock, up from their previous target price of $92.00.

Paycor HCM (NASDAQ:PYCR) was upgraded by analysts at TD Cowen from a hold rating to a buy rating. The firm currently has $22.00 target price on the stock, up from their previous target price of $18.00.

Runway Growth Finance (NASDAQ:RWAY) was upgraded by analysts at Wells Fargo & Company from an equal weight rating to an overweight rating. Wells Fargo & Company currently has $11.00 price target on the stock.

Southern Copper (NYSE:SCCO) was upgraded by analysts at JPMorgan Chase & Co. from an underweight rating to a neutral rating. JPMorgan Chase & Co. currently has $92.50 price target on the stock.

Stryker (NYSE:SYK) was upgraded by analysts at Morgan Stanley from an equal weight rating to an overweight rating. The firm currently has $445.00 price target on the stock, up from their previous price target of $370.00.

Tandem Diabetes Care (NASDAQ:TNDM) was upgraded by analysts at Morgan Stanley from an equal weight rating to an overweight rating. The firm currently has $45.00 target price on the stock.

Tesla (NASDAQ:TSLA) was upgraded by analysts at Roth Mkm from a neutral rating to a buy rating. Roth Mkm currently has $380.00 target price on the stock, up from their previous target price of $85.00.

Xencor (NASDAQ:XNCR) was upgraded by analysts at Piper Sandler from a neutral rating to an overweight rating. Piper Sandler currently has $30.00 target price on the stock, up from their previous target price of $20.00.

Zebra Technologies (NASDAQ:ZBRA) was upgraded by analysts at Morgan Stanley from an underweight rating to an equal weight rating. Morgan Stanley currently has $400.00 price target on the stock, up from their previous price target of $305.00.